These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 27449499

  • 1. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
    Guo K, Cui J, Quan M, Xie D, Jia Z, Wei D, Wang L, Gao Y, Ma Q, Xie K.
    Clin Cancer Res; 2017 Feb 01; 23(3):687-696. PubMed ID: 27449499
    [Abstract] [Full Text] [Related]

  • 2. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.
    Yang H, Hu J, Chen J, Chen Z, Jiao F, Cui J, Quan M, Wang L.
    Med Oncol; 2020 Aug 11; 37(9):84. PubMed ID: 32780197
    [Abstract] [Full Text] [Related]

  • 3. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
    Zhou L, Sheng W, Jia C, Shi X, Cao R, Wang G, Lin Y, Zhu F, Dong Q, Dong M.
    J Cell Mol Med; 2020 Sep 11; 24(18):10560-10572. PubMed ID: 32779876
    [Abstract] [Full Text] [Related]

  • 4. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J.
    J Exp Clin Cancer Res; 2018 Jul 03; 37(1):130. PubMed ID: 29970191
    [Abstract] [Full Text] [Related]

  • 5. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L, Nakano K, Obchoei S, Setoguchi K, Matsumoto M, Yamamoto T, Obika S, Shimada K, Hiraoka N.
    Gastroenterology; 2017 Jul 03; 153(1):292-306.e2. PubMed ID: 28390868
    [Abstract] [Full Text] [Related]

  • 6. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
    Yang Z, Li D, Liu Z, Miao X, Yang L, Zou Q, Yuan Y.
    Cancer Biomark; 2016 Jul 03; 17(4):437-444. PubMed ID: 27802195
    [Abstract] [Full Text] [Related]

  • 7. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z, Yu Z, Wang J, Zhou L, Zhang J, Yao B, Dou J, Qiu Z, Huang C.
    Cell Physiol Biochem; 2018 Jul 03; 46(1):238-252. PubMed ID: 29587259
    [Abstract] [Full Text] [Related]

  • 8. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
    Li Z, Jia Z, Gao Y, Xie D, Wei D, Cui J, Mishra L, Huang S, Zhang Y, Xie K.
    Clin Cancer Res; 2015 Feb 15; 21(4):844-53. PubMed ID: 25501129
    [Abstract] [Full Text] [Related]

  • 9. KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis.
    Yan Y, Li Z, Kong X, Jia Z, Zuo X, Gagea M, Huang S, Wei D, Xie K.
    Cancer Res; 2016 Apr 15; 76(8):2419-31. PubMed ID: 26880805
    [Abstract] [Full Text] [Related]

  • 10. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
    Li W, Chen C, Zhao X, Ye H, Zhao Y, Fu Z, Pan W, Zheng S, Wei L, Nong T, Li Z, Chen R.
    J Cell Mol Med; 2017 Nov 15; 21(11):2896-2908. PubMed ID: 28544376
    [Abstract] [Full Text] [Related]

  • 11. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY, Hsu CC, Wang TY, Li CR, Hou YC, Chu JM, Lee CT, Liu MS, Su JJ, Jian KY, Huang SS, Jiang SS, Shan YS, Lin PW, Shen YY, Lee MT, Chan TS, Chang CC, Chen CH, Chang IS, Lee YL, Chen LT, Tsai KK.
    Gastroenterology; 2013 Nov 15; 145(5):1110-20. PubMed ID: 23896173
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y, Liu Z, Gou S.
    Oncotarget; 2016 Mar 22; 7(12):14912-24. PubMed ID: 26908446
    [Abstract] [Full Text] [Related]

  • 13. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
    Huang Y, Nahar S, Nakagawa A, Fernandez-Barrena MG, Mertz JA, Bryant BM, Adams CE, Mino-Kenudson M, Von Alt KN, Chang K, Conery AR, Hatton C, Sims RJ, Fernandez-Zapico ME, Wang X, Lillemoe KD, Fernández-Del Castillo C, Warshaw AL, Thayer SP, Liss AS.
    Clin Cancer Res; 2016 Aug 15; 22(16):4259-70. PubMed ID: 27169995
    [Abstract] [Full Text] [Related]

  • 14. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9.
    Zhan J, Song J, Wang P, Chi X, Wang Y, Guo Y, Fang W, Zhang H.
    Cancer Lett; 2015 May 28; 361(1):75-85. PubMed ID: 25724625
    [Abstract] [Full Text] [Related]

  • 15. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
    Wang YH, Sui YN, Yan K, Wang LS, Wang F, Zhou JH.
    Oncol Rep; 2015 Apr 28; 33(4):1699-706. PubMed ID: 25647019
    [Abstract] [Full Text] [Related]

  • 16. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH, Wang Y, Yang JY, Li J, Feng MX, Wang YH, Yang XM, He P, Tian GA, Zhang XX, Li Q, Cao XY, Huo YM, Yang MW, Fu XL, Li J, Liu DJ, Dai M, Wen SY, Gu JR, Hong J, Hua R, Zhang ZG, Sun YW.
    Oncotarget; 2016 Jan 26; 7(4):4226-40. PubMed ID: 26735172
    [Abstract] [Full Text] [Related]

  • 17. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
    Sheng W, Dong M, Chen C, Wang Z, Li Y, Wang K, Li Y, Zhou J.
    FASEB J; 2017 Jun 26; 31(6):2429-2438. PubMed ID: 28223335
    [Abstract] [Full Text] [Related]

  • 18. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14.
    Du Y, Liu Z, You L, Hou P, Ren X, Jiao T, Zhao W, Li Z, Shu H, Liu C, Zhao Y.
    Cancer Res; 2017 May 15; 77(10):2661-2673. PubMed ID: 28280038
    [Abstract] [Full Text] [Related]

  • 19. KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells.
    Zhang D, Dai Y, Cai Y, Suo T, Liu H, Wang Y, Cheng Z, Liu H.
    Tumour Biol; 2016 Mar 15; 37(3):3425-31. PubMed ID: 26449825
    [Abstract] [Full Text] [Related]

  • 20. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
    Funel N, Morelli M, Giovannetti E, Del Chiaro M, Pollina LE, Mosca F, Boggi U, Cavazzana A, Campani D.
    Pancreatology; 2011 Mar 15; 11(1):30-42. PubMed ID: 21412023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.